Uptravi for Treatment of PAH Gets Postive Opinion from EMA Committee; EC Decision Expected Soon
News, Pulmonary Hypertension
Actelion recently announced in a press release that the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has reconsidered and re-adopted its positive opinion for the ... Read more